Yagudin, T.,
Zhao, Y.,
Gao, H.,
Zhang, Y.,
Yang, Y.,
Zhang, X.,
Ma, W.,
Daba, T.M.,
Ishmetov, V.,
Kang, K.,
Yang, B.,
Pan, Z. (2020)
infarction in order to facilitate the development of novel therapy.
Inhibitor of
apoptosisYagudin, T,
Zhao, Y,
Gao, HY,
Zhang, Y,
Yang, Y,
Zhang, XF,
Ma, WB,
Daba, TM,
Ishmetov, V,
Kang, K,
Yang, BF,
Pan, ZW (2021) infarction in order to facilitate the development of novel therapy.
Inhibitor of
apoptosisQian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) Myeloid differential
protein-2 (MD2) has been shown to play a critical role in the progression
Rodkin, Stanislav,
Nwosu, Chizaram,
Raevskaya, Margarita,
Khanukaev, Maxim,
Bekova, Khava,
Vasilieva, Inna,
Vishnyak, Diana,
Tolmacheva, Anastasia,
Efremova, Elena,
Gasanov, Mitkhat,
Tyurin, Anton (2023) . It is characterized by various molecular–cellular events, with the main ones being
apoptosis and damage to axons
on the activity of hydrolytic enzymes (amylases and proteinases) and their
protein inhibitors in the leaves
YARULLINA, L.G.,
KASIMOVA, R.I.,
AKHATOVA, A.R.,
MAKSIMOV, I.V.,
IBRAGIMOV, R.I.,
TSVETKOV, V.O.,
YARULLINA, L.M. (2016) of acetylation (DA) on gene expression of protective
proteins (oxalate oxidase, peroxidase, proteinase
inhibitorsIntroduction Bone morphogenetic
proteins (BMPs) are members of a large family of growth factors